Natalie LaFranzo, Ph.D. is VP, Market Development of Cofactor Genomics
World chess champion Garry Kasparov made headlines all over the world in 1997 for something that he probably wasn’t very excited about. He lost a chess match. To a computer.
It was an IBM supercomputer called Deep Blue and its victory in that New York City match marked the first time a reigning world chess champion had been defeated by a computer under tournament conditions. It was also a symbolically significant event,
Read More
UChicago Medicine Selects Life Image’s Breast Health Data Tool
- UChicago Medicine working with Mammosphere by Life Image to allow patients easy, secure access to their breast imaging and to support the WISDOM Study to establish screening guidelines. - Mammosphere was developed to support women throughout their entire breast health journey, including contributing to scientific research. By offering patients this digital tool, patients in the WISDOM Study will have additional tools to support their long-term commitment to the research.Life Image, the world’s
Read More
Geisinger Launches Solution for Women to Request, Store, and Share Breast Health Records
- Geisinger has selected Life Image’s Mammosphere solution to enhance its breast health care offering for women. - Mammosphere is a digital tool that allows women to request, store, and share their breast health records, including prior mammograms, which are essential for accurate and efficient cancer detection.- By putting women in control of their own prior images and records, Mammosphere is overcoming some of the biggest hurdles in breast health management — helping Geisinger to streamline
Read More
Livongo, Pager, Wildflower Health, Others Name BCBS Data Innovation Challenge Finalists
The Blue Cross Blue Shield Association (BCBSA) and Blue Health Intelligence® (BHI) has announced the finalists of the BlueCross BlueShield Data Innovation Challenge developing solutions that increase access to care, enhance patient engagement, and improve care delivery and outcomes. The selected finalists will receive access to a limited HIPAA-compliant Blue Health Intelligence (BHI) dataset so they can test their hypotheses.5 BCBS Data Innovation Challenge FinalistsThe five finalists were
Read More
Mayo Clinic Backs Imago Systems to “Re-Visualize” The Mammogram for Breast Cancer Detection
Mayo Clinic has signed a know-how license agreement with Imago Systems, a medical imaging company with an advanced machine learning software that is designed to dramatically improve a clinician’s ability to detect cancer and other abnormalities earlier and more accurately. Imago Pilot DetailsAs part of the know-how license agreement, a breast imaging research specialist at Mayo Clinic will spearhead Imago's pilot and pivotal studies to clinically validate Imago's visual intelligence software as
Read More
Adventist Integrates CancerIQ Platform with Cerner EHR Systemwide to Get AHEAD of Cancer
Adventist Health is getting AHEAD of hereditary cancer (which tends to be earlier onset, more aggressive, and accounts for 10 percent of all new diagnoses). The Adventist Health Early All-Around Detection – or AHEAD Program – at Adventist Health is a population hereditary cancer risk assessment initiative.To ensure patients in both urban and rural settings have access to the preventive services needed to reduce risk, Adventist Health is partnering with CancerIQ to identify candidates for genetic
Read More
RefleXion Medical Receives $60M Loan for Biology Guiding Radiotherapy Machine
RefleXion Medical, Inc., a biotargeting oncology company developing the first and only biology-guided radiotherapy (BgRT) machine* for targeted cancer treatment has received a $60M senior secured term loan from Oxford Finance LLC. The company plans to use the loan to support the completion of the FDA clearance process for its biology-guided BgRT system and its subsequent commercial launch.
Building from Positron
Emission Tomography
Positron emission tomography (PET) is an established
Read More
Guardant Health to Acquire Cancer Diagnostic Company Bellwether Bio
Precision oncology company Guardant Health, Inc., announced that it
has entered into a definitive agreement to acquire
Seattle-based Bellwether Bio, an
oncology startup developing next generation cancer diagnostics using cell-free
DNA. The acquisition is expected to close in April 2019. Financial terms of the
acquisition were not disclosed.
Bellwether Bio Background
Spun out of the University of Washington in 2016, Bellwether
Bio (formerly known as Haverhill Genetics) is developing
Read More
Proscia Raises $8M for AI-Enhanced Digital Pathology for Cancer Diagnosis
Proscia, a Philadelphia-based digital pathology platform has raised $8.3 million in Series A funding led by Boston-based Flybridge Capital Partners with participation from Emerald Development Managers, Fusion Fund, Razor’s Edge Ventures, and RobinHood Ventures.The startup plans to utilize the Series A funding to fuel the development and commercialization of new, clinical AI-enabled workflows targeting high-volume, high-impact cancers, the first of which will be available later this year. In
Read More
Elsevier Acquires Clinical Decision Support Solution Via Oncology
Elsevier, the information analytics business specializing in science and health, and part of RELX Group, today announced that it has acquired Via Oncology, a Pittsburgh, Pennsylvania-based company that provides clinical decision support and best practices in cancer care management. A former subsidiary of UPMC, one of the nation's leading integrated healthcare delivery and financing systems, Via Oncology helps cancer centers demonstrate the value of their care to patients, referring physicians
Read More
